Click here to get full coverage on How (PLSE) Movements Inform Risk Allocation Models - Stock Traders Daily

How (PLSE) Movements Inform Risk Allocation Models  Stock Traders Daily

How (PLSE) Movements Inform Risk Allocation Models - Stock Traders Daily

Click here to get full coverage on Assessing Pulse Biosciences (PLSE) Valuation After Positive nPulse Cardiac Catheter Study Update - simplywall.st

Assessing Pulse Biosciences (PLSE) Valuation After Positive nPulse Cardiac Catheter Study Update  simplywall.st

Assessing Pulse Biosciences (PLSE) Valuation After Positive nPulse Cardiac Catheter Study Update - simplywall.st

Click here to get full coverage on Pulse Biosciences (PLSE) Reports Promising Clinical Results for Cardiac Catheter System - GuruFocus

Pulse Biosciences (PLSE) Reports Promising Clinical Results for Cardiac Catheter System  GuruFocus

Pulse Biosciences (PLSE) Reports Promising Clinical Results for Cardiac Catheter System - GuruFocus

Click here to get full coverage on Atrial fibrillation catheter logs 60-minute procedures, 96% success - Stock Titan

Atrial fibrillation catheter logs 60-minute procedures, 96% success  Stock Titan

Atrial fibrillation catheter logs 60-minute procedures, 96% success - Stock Titan

Click here to get full coverage on How Low Can PLSE Really Go In A Market Crash? - Trefis

How Low Can PLSE Really Go In A Market Crash?  Trefis

How Low Can PLSE Really Go In A Market Crash? - Trefis

Click here to get full coverage on Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy? - Yahoo Finance

Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy?  Yahoo Finance

Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy? - Yahoo Finance

Click here to get full coverage on $PLSE stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

$PLSE stock is down 13% today. Here's what we see in our data.  Quiver Quantitative

$PLSE stock is down 13% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System - TradingView

Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System  TradingView

Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System - TradingView

Click here to get full coverage on Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial - Yahoo Finance

Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial  Yahoo Finance

Pulse Biosciences (PLSE) Enrolls Its First Patients in a Pivotal Atrial Fibrillation Trial - Yahoo Finance

Click here to get full coverage on Trading Systems Reacting to (PLSE) Volatility - Stock Traders Daily

Trading Systems Reacting to (PLSE) Volatility  Stock Traders Daily

Trading Systems Reacting to (PLSE) Volatility - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences Stock Drops 13% In A Day, Why You Shouldn Not Be Buying The Stock - Trefis

Pulse Biosciences Stock Drops 13% In A Day, Why You Shouldn Not Be Buying The Stock  Trefis

Pulse Biosciences Stock Drops 13% In A Day, Why You Shouldn Not Be Buying The Stock - Trefis

Click here to get full coverage on Pulse Biosciences (PLSE) updates investor deck with 2026 clinical goals - Stock Titan

Pulse Biosciences (PLSE) updates investor deck with 2026 clinical goals  Stock Titan

Pulse Biosciences (PLSE) updates investor deck with 2026 clinical goals - Stock Titan

Click here to get full coverage on We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance

We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate  Yahoo Finance

We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance

Click here to get full coverage on Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story? - simplywall.st

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story?  simplywall.st

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story? - simplywall.st

Click here to get full coverage on Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? - Yahoo Finance

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts?  Yahoo Finance

Is Pulse Biosciences (PLSE) Pricing Make Sense After Recent Volatility And Cash Flow Forecasts? - Yahoo Finance

Click here to get full coverage on How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance

How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh  Yahoo Finance

How Investors May Respond To Pulse Biosciences (PLSE) AF Data Reveal And Boardroom Refresh - Yahoo Finance

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates  Yahoo Finance

Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed?  Yahoo Finance

Pulse Biosciences (PLSE) Is Down 7.9% After FDA OK for Cardiac Device Trials and Q3 Losses – Has the Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Assessing Pulse Biosciences (PLSE) Valuation After Leadership Changes To Advance nPulse Cardiac Ablation System - simplywall.st

Assessing Pulse Biosciences (PLSE) Valuation After Leadership Changes To Advance nPulse Cardiac Ablation System  simplywall.st

Assessing Pulse Biosciences (PLSE) Valuation After Leadership Changes To Advance nPulse Cardiac Ablation System - simplywall.st

Click here to get full coverage on PLSE SEC Filings - Pulse Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

PLSE SEC Filings - Pulse Biosciences Inc 10-K, 10-Q, 8-K Forms  Stock Titan

PLSE SEC Filings - Pulse Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Is Pulse Biosciences’ (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? - Yahoo Finance

Is Pulse Biosciences’ (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy?  Yahoo Finance

Is Pulse Biosciences’ (PLSE) Thyroid Cancer Feasibility Study a Prelude to a Broader Platform Strategy? - Yahoo Finance

Click here to get full coverage on PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - Zacks Investment Research

PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data  Zacks Investment Research

PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - Zacks Investment Research

Click here to get full coverage on Pulse Biosciences (PLSE) to Showcase Innovations at Heart Rhythm Society 2026 Meeting - GuruFocus

Pulse Biosciences (PLSE) to Showcase Innovations at Heart Rhythm Society 2026 Meeting  GuruFocus

Pulse Biosciences (PLSE) to Showcase Innovations at Heart Rhythm Society 2026 Meeting - GuruFocus

Click here to get full coverage on PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data - Zacks Investment Research

PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data  Zacks Investment Research

PLSE Accelerates Cardiac Catheter Program After Breakthrough AFib Data - Zacks Investment Research

Click here to get full coverage on With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently - Yahoo Finance

With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently  Yahoo Finance

With 73% ownership, insiders at Pulse Biosciences, Inc. (NASDAQ:PLSE) are pretty optimistic and have been buying recently - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) awards CTO 100,000 Restricted Stock Units - Stock Titan

Pulse Biosciences (PLSE) awards CTO 100,000 Restricted Stock Units  Stock Titan

Pulse Biosciences (PLSE) awards CTO 100,000 Restricted Stock Units - Stock Titan

Click here to get full coverage on First 7 patients get Pulse catheter in pivotal AFib trial - Stock Titan

First 7 patients get Pulse catheter in pivotal AFib trial  Stock Titan

First 7 patients get Pulse catheter in pivotal AFib trial - Stock Titan

Click here to get full coverage on Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ...  Yahoo Finance

Pulse Biosciences Inc (PLSE) Q3 2025 Earnings Call Highlights: Regulatory Milestones and Early ... - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (PLSE) hires new COO with large inducement equity grants - Stock Titan

Pulse Biosciences (PLSE) hires new COO with large inducement equity grants  Stock Titan

Pulse Biosciences (PLSE) hires new COO with large inducement equity grants - Stock Titan

Click here to get full coverage on Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial  Yahoo Finance

Pulse Biosciences, Inc. (PLSE) Advances Cardiac Care with FDA-Approved Atrial Fibrillation Trial - Yahoo Finance

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Trading 10.1% Higher - Here's Why - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Trading 10.1% Higher - Here's Why  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Trading 10.1% Higher - Here's Why - MarketBeat

Click here to get full coverage on Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute - Stock Titan

Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute  Stock Titan

Chief Commercial Officer exits Pulse Biosciences (PLSE) with no stated dispute - Stock Titan

Click here to get full coverage on Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge? - simplywall.st

Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge?  simplywall.st

Is It Too Late To Consider Pulse Biosciences (PLSE) After Recent Share Price Surge? - simplywall.st

Click here to get full coverage on First patients treated in Pulse Biosciences (NASDAQ: PLSE) NANOPULSE-AF AFib trial - Stock Titan

First patients treated in Pulse Biosciences (NASDAQ: PLSE) NANOPULSE-AF AFib trial  Stock Titan

First patients treated in Pulse Biosciences (NASDAQ: PLSE) NANOPULSE-AF AFib trial - Stock Titan

Click here to get full coverage on Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - Zacks Investment Research

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study  Zacks Investment Research

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - Zacks Investment Research

Click here to get full coverage on Needham healthcare conference to feature Pulse Biosciences on Apr. 16 - Stock Titan

Needham healthcare conference to feature Pulse Biosciences on Apr. 16  Stock Titan

Needham healthcare conference to feature Pulse Biosciences on Apr. 16 - Stock Titan

Click here to get full coverage on Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - ChartMill

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting  ChartMill

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - ChartMill

Click here to get full coverage on How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - Stock Traders Daily

How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing  Stock Traders Daily

How Pulse Biosciences Inc (PLSE) Affects Rotational Strategy Timing - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a Potential 12.99% Upside in the Healthcare Sector - DirectorsTalk Interviews

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a Potential 12.99% Upside in the Healthcare Sector  DirectorsTalk Interviews

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a Potential 12.99% Upside in the Healthcare Sector - DirectorsTalk Interviews

Click here to get full coverage on Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ) - Seeking Alpha

Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ)  Seeking Alpha

Pulse Biosciences stock slips despite Q4 beat (PLSE:NASDAQ) - Seeking Alpha

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 11.7% - Here's Why - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 11.7% - Here's Why  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Stock Price Down 11.7% - Here's Why - MarketBeat

Click here to get full coverage on How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study  Yahoo Finance

How Investors Are Reacting To Pulse Biosciences (PLSE) Gaining FDA Clearance for NANOCLAMP AF Study - Yahoo Finance

Click here to get full coverage on Pulse Biosciences posts updated investor deck with pivotal nsPFA cardiac study details - TradingView

Pulse Biosciences posts updated investor deck with pivotal nsPFA cardiac study details  TradingView

Pulse Biosciences posts updated investor deck with pivotal nsPFA cardiac study details - TradingView

Click here to get full coverage on Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Business Wire

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting  Business Wire

Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting - Business Wire

Click here to get full coverage on Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView

Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results  TradingView

Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView

Click here to get full coverage on Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences - TradingView

Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences  TradingView

Liane R. Teplitsky named Chief Operating Officer at Pulse Biosciences - TradingView

Click here to get full coverage on Pulse Biosciences (PLSE) clarifies disclosure on CCO Kevin Danahy’s resignation - Stock Titan

Pulse Biosciences (PLSE) clarifies disclosure on CCO Kevin Danahy’s resignation  Stock Titan

Pulse Biosciences (PLSE) clarifies disclosure on CCO Kevin Danahy’s resignation - Stock Titan

Click here to get full coverage on Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis

Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst  Trefis

Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis

Click here to get full coverage on Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million - Investing.com

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million  Investing.com

Pulse Biosciences (PLSE) director Duggan buys shares worth $2.79 million - Investing.com

Click here to get full coverage on Pulse Biosciences to Host Analyst Event on April 25, 2026 - Business Wire

Pulse Biosciences to Host Analyst Event on April 25, 2026  Business Wire

Pulse Biosciences to Host Analyst Event on April 25, 2026 - Business Wire

Click here to get full coverage on Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - TradingView

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study  TradingView

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - TradingView

Click here to get full coverage on Pulse Biosciences Heart Device Data Fuels Stock Surge - Benzinga

Pulse Biosciences Heart Device Data Fuels Stock Surge  Benzinga

Pulse Biosciences Heart Device Data Fuels Stock Surge - Benzinga

Click here to get full coverage on PLSE Stock Analysis: Pulse Biosciences Inc 23 USD slight dip performance review - Cổng thông tin điện tử tỉnh Tây Ninh

PLSE Stock Analysis: Pulse Biosciences Inc 23 USD slight dip performance review  Cổng thông tin điện tử tỉnh Tây Ninh

PLSE Stock Analysis: Pulse Biosciences Inc 23 USD slight dip performance review - Cổng thông tin điện tử tỉnh Tây Ninh

Click here to get full coverage on Minimally invasive thyroid cancer study tests alternative to surgery - Stock Titan

Minimally invasive thyroid cancer study tests alternative to surgery  Stock Titan

Minimally invasive thyroid cancer study tests alternative to surgery - Stock Titan

Click here to get full coverage on Pulse Biosciences (PLSE) Initiates Key Clinical Trial for Cardia - GuruFocus

Pulse Biosciences (PLSE) Initiates Key Clinical Trial for Cardia  GuruFocus

Pulse Biosciences (PLSE) Initiates Key Clinical Trial for Cardia - GuruFocus

Click here to get full coverage on Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Business Wire

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium  Business Wire

Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Business Wire

Click here to get full coverage on Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck - Stock Titan

Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck  Stock Titan

Pulse Biosciences (NASDAQ: PLSE) releases updated March 2026 investor deck - Stock Titan

Click here to get full coverage on Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now - Seeking Alpha

Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now  Seeking Alpha

Pulse Biosciences: Promising Catheter Technology, Weak Risk-Reward For Now - Seeking Alpha

Click here to get full coverage on Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily

Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones  Stock Traders Daily

Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily

Click here to get full coverage on Pulse Biosciences Strengthens Executive Leadership Team - TradingView

Pulse Biosciences Strengthens Executive Leadership Team  TradingView

Pulse Biosciences Strengthens Executive Leadership Team - TradingView

Click here to get full coverage on Pulse Biosciences (NASDAQ:PLSE) Shares Down 7% - What's Next? - MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7% - What's Next?  MarketBeat

Pulse Biosciences (NASDAQ:PLSE) Shares Down 7% - What's Next? - MarketBeat

Click here to get full coverage on Pulse Biosciences Strengthens Executive Leadership Team - Business Wire

Pulse Biosciences Strengthens Executive Leadership Team  Business Wire

Pulse Biosciences Strengthens Executive Leadership Team - Business Wire

Click here to get full coverage on Thyroid experts review 15–22 month data on Pulse nPulse ablation - Stock Titan

Thyroid experts review 15–22 month data on Pulse nPulse ablation  Stock Titan

Thyroid experts review 15–22 month data on Pulse nPulse ablation - Stock Titan

Click here to get full coverage on Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen - TradingView

Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen  TradingView

Pulse Biosciences Launches $59.98 Million ATM Equity Program With TD Cowen - TradingView

Click here to get full coverage on Experimental thyroid treatment shrank benign lumps 74% in 22 months - Stock Titan

Experimental thyroid treatment shrank benign lumps 74% in 22 months  Stock Titan

Experimental thyroid treatment shrank benign lumps 74% in 22 months - Stock Titan

Click here to get full coverage on Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 - Investing News Network

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026  Investing News Network

Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 - Investing News Network

Click here to get full coverage on Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - Yahoo Finance

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study  Yahoo Finance

PLSE

Price Chart

Key Statistics

Technicals

About PLSE

Latest News

How (PLSE) Movements Inform Risk Allocation Models - Stock Traders Daily

Assessing Pulse Biosciences (PLSE) Valuation After Positive nPulse Cardiac Catheter Study Update - simplywall.st

Pulse Biosciences (PLSE) Reports Promising Clinical Results for Cardiac Catheter System - GuruFocus

Advanced Charts

Top Gainers

Top Losers